Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analytical goals for interference.

X Fuentes-Arderiu1, C G Fraser

  • 1Servei de Bioquímica Clínica, Hospital Prínceps d'Espanya, Barcelona, Spain.

Annals of Clinical Biochemistry
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidelines to Subcontracting Clinical Laboratory Examinations a Proposal of the Catalan Association for Clinical Laboratory Sciences.

EJIFCC·2018
Same author

Scottish Bowel Screening Programme colonoscopy quality - scope for improvement?

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2018
Same author

Participation in bowel screening among men attending abdominal aortic aneurysm screening.

The British journal of surgery·2018
Same author

Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2013
Same author

Low faecal haemoglobin concentration potentially rules out significant colorectal disease.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2012
Same author

The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study.

British journal of cancer·2012
Same journal

Limitations of spectrophotometry in the analysis of cerebrospinal fluid bilirubin.

Annals of clinical biochemistry·2026
Same journal

Commentary on the impact of lithium heparin vacutainer tubes on daily cerebrospinal fluid analysis.

Annals of clinical biochemistry·2026
Same journal

Routine laboratory triage for NT-proBNP elevation may reflect cardiorenal frailty as much as heart failure specificity.

Annals of clinical biochemistry·2026
Same journal

From interpretable NT-proBNP prediction to equitable laboratory stewardship.

Annals of clinical biochemistry·2026
Same journal

Serum Sclerostin Levels in Children with Osteogenesis Imperfecta.

Annals of clinical biochemistry·2026
Same journal

Population-Specific HOMA-IR Reference Ranges in Iraq: Defining Insulin Sensitivity in a Middle Eastern Cohort.

Annals of clinical biochemistry·2026
See all related articles

We propose analytical goals for interference in clinical biochemistry. Maximum allowable systematic error from an interferent is defined to ensure reliable test results, considering biological variation.

Area of Science:

  • Clinical Biochemistry
  • Analytical Chemistry
  • Medical Diagnostics

Background:

  • Establishing objective analytical goals for interference in clinical biochemical methods is crucial for diagnostic accuracy.
  • Current guidelines lack specific targets for managing interferent effects.
  • Interference can arise from various sources, including non-specificity, matrix effects, and carryover, impacting test reliability.

Purpose of the Study:

  • To propose a framework for setting objective analytical goals for interference in clinical biochemical methods.
  • To define a quantifiable metric for the maximum allowable systematic error introduced by interferents.
  • To ensure that analytical interference does not compromise the interpretation of patient results.

Main Methods:

  • The proposed goal is based on the principle that total analytical error should be less than half the within-subject biological coefficient of variation (CVI).

Related Experiment Videos

  • A formula was derived: Maximum allowable systematic error (I) < CVI - (1.96 * CVA + SE).
  • CVA represents experimental analytical imprecision, and SE represents systematic error.

    • Main Results:

    • The derived formula provides a quantitative target for assessing the impact of interferents.
    • This goal aims to limit systematic error from interferents to maintain analytical quality.
    • The proposed framework is potentially applicable to various interference types, including non-specificity, matrix effects, and carryover.

    Conclusions:

    • The proposed analytical goal offers a scientifically sound approach to managing interference in clinical biochemistry.
    • Implementing such goals will enhance the reliability and accuracy of diagnostic testing.
    • This framework supports the development of more robust and dependable clinical laboratory methods.